Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Morand

Showing results (101-110 of 226) with videos related to

Pageof 23
Sort By:
Brain Research|June 17, 2014
GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathologyAngeline S Thiagarajah, Laura E Eades, Prabakar R Thomas, et al.
Lupus|March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working groupWils Nielsen, Vibeke Strand, Lee S Simon, et al.
The Lancet. Rheumatology|January 30, 2024
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumabVibeke Strand, Sean O'Quinn, Richard A Furie, et al.
The Lancet. Rheumatology|January 30, 2024
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trialsEric F Morand, Richard A Furie, Ian N Bruce, et al.
The Lancet. Rheumatology|January 31, 2024
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS studyMatteo Piga, Elisabetta Chessa, Eric F Morand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2011
Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPaseHuapeng Fan, Pam Hall, Leilani L Santos, et al.
Arthritis and Rheumatism|July 9, 2003
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritisMichelle Leech, Derek Lacey, Jin Rong Xue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritisDragana Odobasic, Yuan Yang, Ruth C M Muljadi, et al.
Journal of Translational Autoimmunity|September 22, 2025
Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatmentZhi Feng Sherman Lim, Alberta Y Hoi, Fabien B Vincent, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factorMyew-Ling Toh, Daniel Aeberli, Derek Lacey, et al.
Pageof 23

Showing results (101-110 of 226) with videos related to

Sort By:
Pageof 23
Brain Research|June 17, 2014
GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathologyAngeline S Thiagarajah, Laura E Eades, Prabakar R Thomas, et al.
Lupus|March 13, 2023
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working groupWils Nielsen, Vibeke Strand, Lee S Simon, et al.
The Lancet. Rheumatology|January 30, 2024
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumabVibeke Strand, Sean O'Quinn, Richard A Furie, et al.
The Lancet. Rheumatology|January 30, 2024
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trialsEric F Morand, Richard A Furie, Ian N Bruce, et al.
The Lancet. Rheumatology|January 31, 2024
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS studyMatteo Piga, Elisabetta Chessa, Eric F Morand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2011
Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPaseHuapeng Fan, Pam Hall, Leilani L Santos, et al.
Arthritis and Rheumatism|July 9, 2003
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritisMichelle Leech, Derek Lacey, Jin Rong Xue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritisDragana Odobasic, Yuan Yang, Ruth C M Muljadi, et al.
Journal of Translational Autoimmunity|September 22, 2025
Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatmentZhi Feng Sherman Lim, Alberta Y Hoi, Fabien B Vincent, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factorMyew-Ling Toh, Daniel Aeberli, Derek Lacey, et al.
Pageof 23